These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report. Schwaiger E; Regele H; Wahrmann M; Werzowa J; Haidbauer B; Schmidt A; Böhmig GA Clin Transpl; 2010; ():391-6. PubMed ID: 21696056 [TBL] [Abstract][Full Text] [Related]
4. Treatment of acute antibody-mediated rejection using bortezomib: a case report. Sin YH; Kim YJ; Oh JS; Lee JH; Kim SM; Kim JK Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595 [TBL] [Abstract][Full Text] [Related]
5. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies. Gupta G; Abu Jawdeh BG; Racusen LC; Bhasin B; Arend LJ; Trollinger B; Kraus E; Rabb H; Zachary AA; Montgomery RA; Alachkar N Transplantation; 2014 Jun; 97(12):1240-6. PubMed ID: 24937198 [TBL] [Abstract][Full Text] [Related]
6. Concurrent acute cellular rejection is an independent risk factor for renal allograft failure in patients with C4d-positive antibody-mediated rejection. Matignon M; Muthukumar T; Seshan SV; Suthanthiran M; Hartono C Transplantation; 2012 Sep; 94(6):603-11. PubMed ID: 22932115 [TBL] [Abstract][Full Text] [Related]
8. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay. Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014 [TBL] [Abstract][Full Text] [Related]
9. The clinical and molecular significance of C4d staining patterns in renal allografts. Hayde N; Bao Y; Pullman J; Ye B; Calder BR; Chung M; Schwartz D; Alansari A; de Boccardo G; Ling M; Akalin E Transplantation; 2013 Feb; 95(4):580-8. PubMed ID: 23274969 [TBL] [Abstract][Full Text] [Related]
10. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. Mauiyyedi S; Crespo M; Collins AB; Schneeberger EE; Pascual MA; Saidman SL; Tolkoff-Rubin NE; Williams WW; Delmonico FL; Cosimi AB; Colvin RB J Am Soc Nephrol; 2002 Mar; 13(3):779-787. PubMed ID: 11856785 [TBL] [Abstract][Full Text] [Related]
11. The Relationship of the Severity and Category of Acute Rejection With Intimal Arteritis Defined in Banff Classification to Clinical Outcomes. Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B Transplantation; 2015 Aug; 99(8):e105-14. PubMed ID: 25719260 [TBL] [Abstract][Full Text] [Related]
12. Bortezomib in late antibody-mediated kidney transplant rejection (BORTEJECT Study): study protocol for a randomized controlled trial. Eskandary F; Bond G; Schwaiger E; Kikic Z; Winzer C; Wahrmann M; Marinova L; Haslacher H; Regele H; Oberbauer R; Böhmig GA Trials; 2014 Apr; 15():107. PubMed ID: 24708575 [TBL] [Abstract][Full Text] [Related]
13. The significance of C4d staining with minimal histologic abnormalities. Haas M Curr Opin Organ Transplant; 2010 Feb; 15(1):21-7. PubMed ID: 19907328 [TBL] [Abstract][Full Text] [Related]
14. Acute T cell-mediated rejection accompanied by C4d-negative acute antibody-mediated rejection and cell debris in tubulus: A case report. Takamura T; Yamamoto I; Nakada Y; Katsumata H; Yamakawa T; Furuya M; Mafune A; Kobayashi A; Tanno Y; Miki J; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T Nephrology (Carlton); 2015 Jul; 20 Suppl 2():70-4. PubMed ID: 26031591 [TBL] [Abstract][Full Text] [Related]
15. Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system. Al-Aly Z; Reddivari V; Moiz A; Balasubramanian G; Cortese CM; Salinas-Madrigal L; Bastani B Transpl Int; 2008 Mar; 21(3):268-75. PubMed ID: 18069927 [TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated rejection and treatment in pediatric patients: one center's experience. Gulleroglu K; Baskin E; Bayrakci US; Turan M; Ozdemir BH; Moray G; Karakayali H; Haberal M Exp Clin Transplant; 2013 Oct; 11(5):404-7. PubMed ID: 24128133 [TBL] [Abstract][Full Text] [Related]
17. C4D deposition and positive posttransplant crossmatch are not necessarily markers of antibody-mediated rejection in renal allograft recipients. Banasik M; Boratyńska M; Nowakowska B; Haloń A; Kościelska-Kasprzak K; Drulis-Fajdasz D; Patrzałek D; Weyde W; Klinger M Transplant Proc; 2007 Nov; 39(9):2718-20. PubMed ID: 18021967 [TBL] [Abstract][Full Text] [Related]